Fractyl Health, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Fractyl Health, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Fractyl Health, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $280.00K, a 71.78% increase year-over-year.
- Fractyl Health, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $220.00K, a 4300.00% increase year-over-year.
- Fractyl Health, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $16.00K, a 46.67% decline year-over-year.
- Fractyl Health, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $280.00K, a 51.05% decline from fiscal 2024.
- Fractyl Health, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $572.00K, a 1000.00% increase from fiscal 2023.
- Fractyl Health, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $52.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $280.00K 10-K · filed 2026-03-24 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $280.00K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $572.00K 10-K · filed 2026-03-24 | |
| 2024-09-30 | $220.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $16.00K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $163.00K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $52.00K 10-K · filed 2025-03-03 | |
| 2023-09-30 | $5.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $30.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |